In an effort to discover novel oligonucleotide modifications for antisense therapeutics, we have prepared oligodeoxyribonucleotides containing more than 200 different modifications …
DD Weller, JN Hassinger, BZ Cai - US Patent 7,943,762, 2011 - Google Patents
Morpholino oligomers containing both uncharged and cationic intersubunit linkages are provided. The oligomers are oligonucleotide analogs containing predetermined sequences …
PL Iversen - US Patent 6,677,153, 2004 - Google Patents
The invention relates to compositions comprising oligomers antisense to bacterial 16S or 23S rRNA and capable of Selectively modulating the biological activity thereof, and methods …
S Gryaznov, T Skorski, C Cucco… - Nucleic Acids …, 1996 - academic.oup.com
Uniformly modified oligonucleotide N3′→ P5′ phosphoramidates, where every 3′- oxygen is replaced by a 3′-amino group, were synthesized. These compounds have very …
S Gryaznov, RG Schultz - US Patent 5,684,143, 1997 - Google Patents
A new class of oligonucleotide N3'→ P5'phosphoramidates having 2'fluoro substituents are provided that have superior acid stability. The invention includes oligo-2'-fluoronucleotide …
In recent years, research in organophosphorus chemistry has mainly focused in designing newer and better phosphorus ligands for synthesizing novel metal complexes with improved …
PL Iversen, HK Roy, RK Bestwick - US Patent 7,402,574, 2008 - Google Patents
(57) ABSTRACT A method and composition for treating colorectal cancer is disclosed. The method involves administering to a subject, a therapeutically effective amount of a …